Download PDF
Zeitschrift für Phytotherapie 2016; 37(03): 100-104
DOI: 10.1055/s-0042-110171
Forschung
© Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Prophylaxe und Therapie von Atemwegsinfekten mit Echinacea-Extrakten

Andreas Schapowal
Further Information

Publication History

Publication Date:
26 July 2016 (online)

    Permissions and Reprints

Zusammenfassung

Atemwegsinfekte sind primär viraler Genese, können aber auch durch Bakterien bedingt sein oder durch bakterielle Superinfektion kompliziert werden. Die unkritische Verordnung von Antibiotika bei viralen Atemwegsinfekten führt zu unerwünschten Wirkungen v.a. im Gastrointestinaltrakt, Allergien, Antibiotikaresistenz und unnötigen Kosten für das Gesundheitssystem. Zahlreiche pflanzliche Arzneimittel stehen zur Therapie akuter Atemwegsinfekte zur Verfügung. Zur Prophylaxe sowie zur Therapie akuter und rezidivierender Atemwegsinfekte geeignet sind Extrakte aus Echinacea purpurea. Echinaforce®, ein standardisierter, ethanolischer Extrakt aus frischem, blühendem Kraut und den Wurzeln von Echinacea purpurea, wirkt antiviral, antibakteriell und durch Immunmodulation entzündungshemmend. Eine aktuelle Metaanalyse belegt die Verminderung des Risikos von Rezidiven und Komplikationen von Atemwegsinfekten durch Echinacea im Vergleich zu Placebo.

Schlüsselwörter

Echinacea purpurea (L.) Moench - Atemwegserkrankungen - Prophylaxe

Keywords

Echinacea purpurea (L.) Moench - respiratory tract infections - prophylaxis
 

  • Literatur

  • 1 Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002; 112: 13-18
    PubMedGoogle Scholar
  • 2 Fahey T, Stocks N, Thomas T. Quantitative systemic review of randomized controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 1998; 316: 906-910
    CrossrefPubMedGoogle Scholar
  • 3 Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2014; CD000245
    PubMedGoogle Scholar
  • 4 Risnes KR, Belanger K, Murk W, Bracken MB. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 US children. Am J Epidemiol 2011; 173: 310-318
    CrossrefPubMedGoogle Scholar
  • 5 Nasrin D, Collignon PJ, Roberts L et al. Effect of β lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 2002; 324: 28-30
    CrossrefPubMedGoogle Scholar
  • 6 Bronzwaer SL, Cars O, Buchholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-282
    CrossrefPubMedGoogle Scholar
  • 7 WHO. Antimicrobial resistance: global report on surveillance 2014. World Health Organization. URL: http://www.who.int/drugresistance/documents/surveillancereport/en
    PubMedGoogle Scholar
  • 8 Nationale Strategie zur Reduktion von Spital- und Pflegeheiminfektionen (Strategie NOSO). Bundesamt für Gesundheit 2015. URL: https://www.news.admin.ch/message/index.html?lang=de&msg-id=57988
    PubMedGoogle Scholar
  • 9 Persönliche Mitteilung: Prof. Dr. phil. Herbert Hächler, Leiter NENT, Institut für Lebensmittelsicherheit und -hygiene der Universität Zürich http://www.ils.uzh.ch
    PubMed
  • 10 Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev 2007; 12: 25-48
    PubMedGoogle Scholar
  • 11 Hudson JB. The use of herbal extracts in the control of influenza. J Med Plant Res 2009; 3: 1189-1195
    PubMedGoogle Scholar
  • 12 Schapowal A. The triple action of the herbal medicine Echinaforce® in the treatment of colds and flu-like infections. Schweiz Z Ganzheitsmed 2011; 23: 40-44
    CrossrefPubMedGoogle Scholar
  • 13 Schapowal A. Efficacy and safety of Echinaforce® in respiratory tract infections. Wien Med Wochenschr 2013; 163: 102-105
    CrossrefPubMedGoogle Scholar
  • 14 Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res 2009; 83: 165-170
    CrossrefPubMedGoogle Scholar
  • 15 Pleschka S, Stein M, Schoop R, Hudson JB. Antiviral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virology J 2009; 6: 197
    CrossrefPubMedGoogle Scholar
  • 16 Sharma S, Anderson SM, Schoop R, Hudson JB. Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): dual actions against respiratory bacteria. Phytomedicine 2010; 17: 563-568
    CrossrefPubMedGoogle Scholar
  • 17 Sharma M, Schoop R, Hudson JB. Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters. Phytother Res 2009; 23: 863-867
    CrossrefPubMedGoogle Scholar
  • 18 Altamirano-Dimas M, Hudson JB, Cochrane D et al. Modulation of immune response gene expression by Echinacea extracts: results of a gene array analysis. Can J Physiol Pharmacol 2007; 85: 1091-1098
    CrossrefPubMedGoogle Scholar
  • 19 Altamirano-Dimas M, Sharma M, Hudson JB. Echinacea and anti-inflammatory cytokine responses: Results of a gene and protein array analysis. Pharm Biol 2009; 47: 500-508
    CrossrefPubMedGoogle Scholar
  • 20 Sharma M, Schoop R, Hudson JB. The efficacy of Echinacea in a 3-D tissue model of human airway epithelium. Phytother Res 2010; 24: 900-904
    PubMedGoogle Scholar
  • 21 Ritchie MR, Gertsch J, Klein P et al. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells. Phytomed 2011; 18: 826-831
    CrossrefPubMedGoogle Scholar
  • 22 Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Therapeutics 2006; 28: 174-183
    CrossrefPubMedGoogle Scholar
  • 23 Shah SA, Sander S, White cm et al. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis 2007; 7: 473-480
    CrossrefPubMedGoogle Scholar
  • 24 Karsch-Völk M, Barrett B, Kiefer D et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2014; (2): CD000530
    PubMedGoogle Scholar
  • 25 Schapowal A, Klein P, Johnston SL. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials. Adv Ther 2015; 32: 187-200
    CrossrefPubMedGoogle Scholar
  • 26 Schmidt U, Albrecht M, Schenk N. Pflanzliches Immunstimulans senkt Häufigkeit grippaler Infekte. Natur- und Ganzheitsmedizin 1990; 3: 277-281
    PubMedGoogle Scholar
  • 27 Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of cold and respiratory infections. Am J Med 1999; 106: 138-143
    CrossrefPubMedGoogle Scholar
  • 28 Melchart D, Walther E, Linde K et al. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med 1998; 7: 541-545
    CrossrefPubMedGoogle Scholar
  • 29 Cohen HA, Varsano I, Kahan E et al. Effectiveness of an herbal preparation containing echinacea, propolis and vitamin c in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, mutlicenter study. Arch Pediatr Adolesc Med 2004; 158: 217-221
    CrossrefPubMedGoogle Scholar
  • 30 Taylor JA, Weber W, Standish L et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003; 290: 2824-2830
    CrossrefPubMedGoogle Scholar
  • 31 Jawad M, Schoop R, Suter A et al. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med 2012; 2012: 841315
    CrossrefPubMedGoogle Scholar